In the Kaplan-Meier survival analysis, the overall survival time and recurrence-free survival time of cholangiocarcinoma patients with high LINC00665 expression were significantly shortened (Lu et al., 2021). This evidence concerns the gene LINC00665 and cholangiocarcinoma.